2017-03-01
Corrigendum to “Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder – A combined magnetic resonance imaging and positron emission tomography study”
Publication
Publication
[Brain Behav. Immun. (2015)] (S088915911530012X)(10.1016/j.bbi.2015.09.004)
Brain, Behavior, and Immunity , Volume 61 p. 387- 388
While retrieving additional information from patients’ medical files for another study, it became clear that one patient who was actually using valproate and levetiracetam, was previously processed as a lithium user. Below you will find the corrected version of the subjects’ characteristics Table 1, as well as corrected results of the explorative analyses of this study where lithium use was involved and an updated version of Fig. 7, summarizing the explorative analysis results of the left hippocampus. The altered text of the concerned paragraphs are set in boldface. The cited references are as in the original report.
Additional Metadata | |
---|---|
doi.org/10.1016/j.bbi.2016.05.001, hdl.handle.net/1765/98008 | |
Brain, Behavior, and Immunity | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Haarman, B., Burger, H., Doorduin, J., Renken, R., Sibeijn-Kuiper, A. J., Marsman, J.-B. C., … Riemersma-Van der Lek, R. (2017). Corrigendum to “Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder – A combined magnetic resonance imaging and positron emission tomography study”. Brain, Behavior, and Immunity, 61, 387–388. doi:10.1016/j.bbi.2016.05.001 |